Clinical Trial Update: Prasugrel Versus High Dose Clopidogrel in Patients With Stable Coronary Artery Disease and High Platelet Reactivity While on Chronic Clopidogrel Treatment [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing prasugrel to high-dose clopidogrel in patients with stable coronary artery disease and high platelet reactivity who remain on clopidog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Stable Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• PRASUGREL (prasugrel)

Snippet

Sponsor: University of Patras | Conditions: Coronary Artery Disease (CAD) | Phase 3 | Status: COMPLETED